2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73827):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-155869A
    5-fluoro-dCTP sodium 98%
    5-fluoro-dCTP sodium is a fluorinated pyrimidine dNTP that can be used as a substrate for the incorporation of fluorine modification into specific DNA sequences by primer extension (PEX) catalyzed by Pwo polymerase.
    5-fluoro-dCTP sodium
  • HY-155877N
    mPEG-DSPE (MW 5000) sodium 459428-35-4 98.0%
    mPEG-DSPE (MW 5000) sodium is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. mPEG-DSPE (MW 5000) sodium can be used in drug delivery research.
    mPEG-DSPE (MW 5000) sodium
  • HY-158995S
    3-Epiglycyrrhetinic acid-d2
    3-Epiglycyrrhetinic acid-d2 (3α-Glycyrrhetic acid-d2) is the deuterium-labeled 3-Epiglycyrrhetinic acid. 3-Epiglycyrrhetinic acid is a derivative of glycyrrhetic acid. Glycyrrhetic acid and its derivative are considered to have anti-inflammatory, anti-ulcer, and antiviral activities.
    3-Epiglycyrrhetinic acid-d2
  • HY-159064S
    DSPSAPVNVT(Val-13C5,15N)R TFA
    DSPSAPVNVT(Val-13C5,15N)R TFA is the 13C and 15N-labeled DSPSAPVNVT(Val)R.
    DSPSAPVNVT(Val-13C5,15N)R TFA
  • HY-159191S
    VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA
    VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI (TFA) is the 13C and 15N labeled isotope of VQPGQN-HMFTKEKLEEVIKDI (TFA).
    VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA
  • HY-159193S
    DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA
    DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT (TFA) is the 13C and 15N labeled isotope of DHATS-PVTIPSAVST-HTTPLPVTDT (TFA).
    DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA
  • HY-160079A
    3′-O-Azidomethyl-dCTP sodium,100 mM Solution 99.11%
    3′-O-Azidomethyl-dCTP sodium,100 mM Solution is a labeled modified deoxyoligonucleotide (dNTP) that can release pyrophosphate to produce fluorescence and has special applications in gene synthesis and sequencing.
    3′-O-Azidomethyl-dCTP sodium,100 mM Solution
  • HY-160773A
    DBCO-C3-amide-PEG6-NHS ester
    DBCO-C3-amide-PEG6-NHS ester is a click chemistry PEG reagent containing an NHS ester that reacts specifically with primary amines, such as side chains of lysine residues or aminosilane-coated surfaces, under neutral or slightly alkaline conditions. , efficient reaction to form covalent bonds. DBCO-C3-amide-PEG6-NHS ester also contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
    DBCO-C3-amide-PEG6-NHS ester
  • HY-161011A
    Spire2-FMN2 PPI-IN-1 dihydrochloride 98.99%
    Spire2/FMN2 PPI-IN-1 (Compound 13) dihydrochloride is a selective inhibitory fragment targeting the Spire2-FMN2 interaction, with an IC50 of 62 μM. Spire2/FMN2 PPI-IN-1 dihydrochloride has affinity for KIND2, with a Kd of 87.7 μM, and does not inhibit KIND1. Spire2/FMN2 PPI-IN-1 dihydrochloride can be used for the development of chemical probes for the Spire2-FMN2 interaction.
    Spire2-FMN2 PPI-IN-1 dihydrochloride
  • HY-163163S
    18:1-21:2-18:1 TG-d5 2342574-90-5 99.00%
    18:1-21:2-18:1 TG-d5 is deuterium labeled 18:1-21:2-18:1 TG.
    18:1-21:2-18:1 TG-d5
  • HY-164182S
    Myristoleyl carnitine-d3 1803252-79-0 99.93%
    Myristoleyl carnitine-d3 is the deuterium labeled Myristoleyl carnitine.
    Myristoleyl carnitine-d3
  • HY-164192A
    m7(3'AcmG)(5')ppp(5')(2'OMeA)pG trisodium solution (100 mM) 98.61%
    m7(3'AcmG)(5')ppp(5')(2'OMeA)pG trisodium, a cap analogue derived from patent WO2023159930A1, can be used for the synthesis of mRNA.
    m7(3'AcmG)(5')ppp(5')(2'OMeA)pG trisodium solution (100 mM)
  • HY-164294A
    Aluminum phthalocyanine disulfonate disodium
    Aluminum phthalocyanine disulfonate disodium is a potential photosensitizer used for the research of Sonodynamic therapy (SDT) .
    Aluminum phthalocyanine disulfonate disodium
  • HY-164556A
    3′-Deoxy-5′-AMP sodium 71997-30-3 98%
    3′-Deoxy-5′-AMP sodiumIt can be used to study various physiological processes such as energy metabolism and information transmission.
    3′-Deoxy-5′-AMP sodium
  • HY-164903A
    UDP-D-GalNAlk disodium 2370947-52-5 98.87%
    UDP-D-GalNAlk disodium is an alkyne-modified UDP sugar and unnatural sugar nucleotide. UDP-D-GalNAlk disodium allows in vitro synthesis via mutant AGX1 enzyme. UDP-D-GalNAlk disodium serves as a substrate for engineered GalNAc-T enzymes, enabling the selective installation of alkyne-modified D-GalNAc derivatives in glycoproteomes. UDP-D-GalNAlk disodium is a biochemical reagent used as a biological material or organic compound for life science research.
    UDP-D-GalNAlk disodium
  • HY-170007S
    5(Z),8(Z)-Tetradecadienoic Acid-d11 98.1%
    5(Z),8(Z)-Tetradecadienoic Acid-d11 is deuterium labeled 5(Z),8(Z)-Tetradecadienoic Acid.
    5(Z),8(Z)-Tetradecadienoic Acid-d11
  • HY-172164B
    FITC-lysine-dextran (MW 70kDa)
    FITC-lysine-dextran, 70kDa is a dextran with lysine coupling with a fluorescent group FITC (HY-66019). Lysine-dextran exhibits higher Glu-plasminogen binding ability than dextran alone.
    FITC-lysine-dextran (MW 70kDa)
  • HY-176034S
    GPAGPQGP-Arg(13C6,15N4) TFA 99.58%
    GPAGPQGP-Arg (13C6,15N4) TFA is a peptide containing 13C6 and 15N4 labeled Arg.
    GPAGPQGP-Arg(13C6,15N4) TFA
  • HY-176710A
    (R)-PAD-PF2 99.95%
    (R)-PAD-PF2 is an isomer of PAD-PF2 (HY-176710). PAD-PF2 is a PAD family inhibitor, as well as a κ-opioid receptor agonist (EC50 = 7.55 μM) and an M1 muscarinic acetylcholine receptor antagonist (IC50 = 12.3 μM).
    (R)-PAD-PF2
  • HY-177596A
    Dicytidine 5′-triphosphate trisodium 1629163-10-5 98%
    Dicytidine 5′-triphosphate (Cp3C) trisodium is a cytosine-containing dinucleoside polyphosphate. Dicytidine 5′-triphosphate trisodium inhibits the intracellular accumulation of trans-resveratrol and trans-piceid. Dicytidine 5′-triphosphate trisodium induces the expression of CCR2 and upregulates the expression of PAL1 and 4CL1.
    Dicytidine 5′-triphosphate trisodium